CannaPharmaRx Inc
OTC:CPMD

Watchlist Manager
CannaPharmaRx Inc Logo
CannaPharmaRx Inc
OTC:CPMD
Watchlist
Price: 0.0032 USD Market Closed
Market Cap: 2.1m USD

Net Margin
CannaPharmaRx Inc

408.3%
Current
-1 754%
Average
5.1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
408.3%
=
Net Income
1.4m
/
Revenue
338k

Net Margin Across Competitors

Country Company Market Cap Net
Margin
CA
CannaPharmaRx Inc
OTC:CPMD
2.1m USD
408%
US
Eli Lilly and Co
NYSE:LLY
663.9B USD
26%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
424.9B USD
25%
CH
Roche Holding AG
SIX:ROG
203.6B CHF
14%
UK
AstraZeneca PLC
LSE:AZN
179.8B GBP
15%
CH
Novartis AG
SIX:NOVN
192.2B CHF
25%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
36%
US
Merck & Co Inc
NYSE:MRK
211.9B USD
26%
IE
Endo International PLC
LSE:0Y5F
183.4B USD
-126%
US
Pfizer Inc
NYSE:PFE
142.9B USD
17%

CannaPharmaRx Inc
Glance View

Market Cap
2.1m USD
Industry
Pharmaceuticals

CannaPharmaRx, Inc. engages in the research and manufacture of cannabinoid-based pharmaceuticals. The company is headquartered in Calgary, Alberta and currently employs 4 full-time employees. The principal activity of the Company is to negotiate, acquire and develop various cannabis cultivation projects throughout Canada. The firm's activities is centered around projects, such as the Great Northern Project, and the acquisition of Ramon Road Production Campus LLC. The firm is focused on producing wholesale cannabis and hemp for the medical market.

CPMD Intrinsic Value
0.001 USD
Overvaluation 70%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
408.3%
=
Net Income
1.4m
/
Revenue
338k
What is the Net Margin of CannaPharmaRx Inc?

Based on CannaPharmaRx Inc's most recent financial statements, the company has Net Margin of 408.3%.

Back to Top